Device selection and outcomes of aerosol therapy: Evidence-based guidelines: American College of Chest Physicians/American College of Asthma, Allergy, and Immunology.
about
Beclometasone for chronic obstructive pulmonary diseaseMetered dose inhalers versus nebulizers for aerosol bronchodilator delivery for adult patients receiving mechanical ventilation in critical care unitsIntravenous beta 2 -agonists versus intravenous aminophylline for acute asthmaMetered dose inhalers versus nebulizers for aerosol bronchodilator delivery for adult patients receiving mechanical ventilation in critical care unitsPharmaceutical policies: effects of restrictions on reimbursementPatients' perspectives and preferences in the choice of inhalers: the case for Respimat(®) or HandiHaler(®)Patient perspectives on fluticasone-vilanterol versus other corticosteroid combination products for the treatment of asthmaAcute exacerbation of COPDInhaler technique: facts and fantasies. A view from the Aerosol Drug Management Improvement Team (ADMIT)Switching treatments in COPD: implications for costs and treatment adherenceImpact of extrafine formulations of inhaled corticosteroids/long-acting beta-2 agonist combinations on patient-related outcomes in asthma and COPD.Rising Costs of COPD and the Potential for Maintenance Therapy to Slow the TrendCharacteristics of patients making serious inhaler errors with a dry powder inhaler and association with asthma-related events in a primary care setting.Fundamentals of aerosol therapy in critical careA review of nebulized drug delivery in COPDSystematic Review and Quality Appraisal of Cost-Effectiveness Analyses of Pharmacologic Maintenance Treatment for Chronic Obstructive Pulmonary Disease: Methodological Considerations and RecommendationsEffectiveness and success factors of educational inhaler technique interventions in asthma & COPD patients: a systematic review.International consensus on (ICON) pediatric asthmaCharacteristics of reversible and nonreversible COPD and asthma and COPD overlap syndrome patients: an analysis of salbutamol Easyhaler data.Inhaled corticosteroids for asthma: impact of practice level device switching on asthma control.Treating osteoporosis in Canada: what clinical efficacy data should be considered by policy decision makers?Asthma that is unresponsive to usual careThe role of omalizumab in the treatment of severe allergic asthma.Patient perspectives in the management of asthma: improving patient outcomes through critical selection of treatment optionsPatient preferences for inhaler devices in chronic obstructive pulmonary disease: experience with Respimat Soft Mist inhalerAsthma in adults (acute).An evaluation of impact of educational interventions on the technique of use of metered-dose inhaler by patients.Chronic obstructive pulmonary disease: an overviewAsthma control in patients receiving inhaled corticosteroid and long-acting beta2-agonist fixed combinations. A real-life study comparing dry powder inhalers and a pressurized metered dose inhaler extrafine formulationDeveloping ways to evaluate in the laboratory how inhalation devices will be used by patients and care-givers: the need for clinically appropriate testing.Integrated management strategies for chronic obstructive pulmonary disease.Ease-of-use, preference, confidence, and satisfaction with Revolizer(®), a novel dry powder inhaler, in an Indian populationSafety and efficacy of fluticasone propionate/salmeterol hydrofluoroalkane 134a metered-dose-inhaler compared with fluticasone propionate/salmeterol diskus in patients with chronic obstructive pulmonary diseaseEvidence for therapeutic uses of nebulized lidocaine in the treatment of intractable cough and asthma.Efficacy and safety of the single-capsule combination of fluticasone/formoterol in patients with persistent asthma: a non-inferiority trial.Misuse of respiratory inhalers in hospitalized patients with asthma or COPD.Evaluation of patient-reported outcomes and quality of life with the I-neb AAD system in patients with chronic obstructive pulmonary diseaseEffectiveness of inhaler types for real-world asthma management: retrospective observational study using the GPRD.Delivery characteristics and patients' handling of two single-dose dry-powder inhalers used in COPD.Cost-effectiveness analysis of corticosteroid inhaler devices in primary care asthma management: A real world observational study.
P2860
Q24197535-69A64344-BEF0-47AC-819C-EE2ED6861C34Q24202085-06F97123-6E65-4849-812F-7EAAD0E9B804Q24202348-93A9F8D3-98E2-4BFD-9339-B9043134F2A5Q24235990-F264CB31-A77A-46D8-8295-DFAC6875CCD1Q24236533-52787A21-13E8-4BFE-BB57-D633D3E48B00Q26738366-1A89786E-E46F-429C-B9FD-AB933C8B020DQ26743444-5BFBADE8-1761-4412-83A0-32D60161975DQ26749302-79A06578-9FE6-4F48-BC9F-C844D3540AB9Q26751471-3892B841-76BD-4C52-8E23-8B2C2FA7ADC2Q26776324-29683062-4077-49A8-AE32-D6D3926A1099Q26826860-58C5F88F-9D6D-4487-BF63-EED49FF989EBQ27026708-7477F220-2AA4-4C0B-8FC5-76EFE732DF62Q27334822-1F8DF0A0-2B11-4573-A56F-68ACC192493FQ28068836-6A8869AE-BB02-408B-9B54-0BAADCD99734Q28075295-20267AA2-45D7-4745-AE8E-CFC68FDABA28Q30245662-5E92EFC5-4EA9-4E85-B9FF-021CA0CC5B25Q30356010-3ADF13F2-A4DA-4794-955F-912BDB3187E8Q30393965-DE1B7736-1913-4087-A40F-04C3E78DC0A7Q31042074-79827B7F-3A01-44C6-855E-53A822F46ABCQ33397155-57F02152-E31B-4AC3-B559-329E3289DA7FQ33416959-718D6683-5987-4DC8-833F-C03D00032B8BQ33575466-3EE07735-11DC-4D6B-9284-B2079327A89CQ33591890-F727376D-AA3F-40A4-8B9B-41E11665484FQ33644839-DBDE5122-2EF3-4274-8834-B1AA3CCB3E49Q33693426-5EA03F34-7E39-49E1-9F2C-7DB885144234Q33862095-C8824A5B-B732-46B1-B6D8-DE159DC4C448Q33872288-84DF501F-6C78-41E4-8436-CDAE46942F89Q33932323-F4AF1919-1023-4149-AC3D-9C5EF95E4AE9Q33962531-78E7F92C-6ED5-4447-8075-5FA7B136DFE1Q34265177-06ACB9CE-1E3C-407F-ADDB-80D16793C156Q34418124-E78A33F5-C1F6-4240-91AA-1B766586EC98Q34453118-32EC893B-C6F8-422A-B4D8-A67A9D99352BQ34501125-41976BF6-551E-4449-998D-3D5F7068AE85Q34645655-2040C79F-BB2C-420F-A28B-67E1CF0FC853Q34993087-023A49A6-3BC3-40EF-B91F-94DA6011FDD2Q35007081-31653624-5ACD-48D9-9252-209A95F814FAQ35049724-E8F0C0AD-F82A-42AA-ACA1-14DE0A008937Q35050201-AD14CC71-BCED-4445-9B75-6208E0C956FEQ35096988-280EE7D1-92AB-4C74-838B-11B672CE5E78Q35205393-3A3A6044-9B49-44AE-B76A-53589131E4EE
P2860
Device selection and outcomes of aerosol therapy: Evidence-based guidelines: American College of Chest Physicians/American College of Asthma, Allergy, and Immunology.
description
2005 nî lūn-bûn
@nan
2005 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Device selection and outcomes ...... thma, Allergy, and Immunology.
@ast
Device selection and outcomes ...... thma, Allergy, and Immunology.
@en
type
label
Device selection and outcomes ...... thma, Allergy, and Immunology.
@ast
Device selection and outcomes ...... thma, Allergy, and Immunology.
@en
prefLabel
Device selection and outcomes ...... thma, Allergy, and Immunology.
@ast
Device selection and outcomes ...... thma, Allergy, and Immunology.
@en
P2093
P50
P356
P1433
P1476
Device selection and outcomes ...... thma, Allergy, and Immunology.
@en
P2093
American College of Asthma, Allergy, and Immunology
Dean R Hess
Gerald C Smaldone
Joseph L Rau
Myrna B Dolovich
Paula Anderson
Richard C Ahrens
P304
P356
10.1378/CHEST.127.1.335
P407
P577
2005-01-01T00:00:00Z